AnuradhaThalasilaMD

PubMed

• Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy.
  DiPaola, R. S., Dvorzhinski, D., Thalasila, A., Garikapaty, V., Doram, D., May, M., Bray, K., Mathew, R., Beaudoin, B., Karp, C., Stein, M., Foran, D. J., White, E.> ;Prostate. 2008 Dec 1
• Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.
  Lee, S. J., Gounder, M., Rubin, E. H., Li, J. M., Gu, Z., Thalasila, A., Loyer, E., Kudelka, A. P., Verschraegen, C. F.> ;Invest New Drugs. 2008 Dec
• A novel proteomic coculture model of prostate cancer cell growth.
  Dvorzhinski, D., Thalasila, A., Thomas, P. E., Nelson, D., Li, H., White, E., Dipaola, R. S.> ;Proteomics. 2004 Oct
• A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies.
  Thalasila, A., Poplin, E., Shih, J., Dvorzhinski, D., Capanna, T., Doyle-Lindrud, S., Beers, S., Goodin, S., Rubin, E., DiPaola, R. S.> ;Cancer Chemother Pharmacol. 2003 Aug
• Join now to see all